Search Results - "Lesniak, M S"

Refine Results
  1. 1

    The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues by Panek, W. K., Toedebusch, R. G., Mclaughlin, B. E., Dickinson, P. J., Van Dyke, J. E., Woolard, K. D., Berens, M. E., Lesniak, M. S., Sturges, B. K., Vernau, K. M., Li, C., Miska, J., Toedebusch, Christine M.

    Published in Journal of neuro-oncology (01-09-2024)
    “…Purpose Spontaneously occurring glioma in pet dogs is increasingly recognized as a valuable translational model for human glioblastoma. Canine high-grade…”
    Get full text
    Journal Article
  2. 2

    Autophagy in glioma cells: An identity crisis with a clinical perspective by Ulasov, I.V., Lenz, G., Lesniak, M.S.

    Published in Cancer letters (01-08-2018)
    “…Over the last decade, autophagy has emerged as one of the critical cellular systems that control homeostasis. Besides management of normal homeostatic…”
    Get full text
    Journal Article
  3. 3

    Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo by Ulasov, I V, Sonabend, A M, Nandi, S, Khramtsov, A, Han, Y, Lesniak, M S

    Published in British journal of cancer (07-04-2009)
    “…Conditionally replicative adenoviruses (CRAds) represent a novel treatment strategy for malignant glioma. Recent studies suggest that the cytopathic effect…”
    Get full text
    Journal Article
  4. 4

    Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo by Tyler, M A, Ulasov, I V, Sonabend, A M, Nandi, S, Han, Y, Marler, S, Roth, J, Lesniak, M S

    Published in Gene therapy (01-02-2009)
    “…Adenoviral oncolytic virotherapy represents an attractive treatment modality for central nervous system (CNS) neoplasms. However, successful application of…”
    Get full text
    Journal Article
  5. 5

    Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction by Morshed, R A, Gutova, M, Juliano, J, Barish, M E, Hawkins-Daarud, A, Oganesyan, D, Vazgen, K, Yang, T, Annala, A, Ahmed, A U, Aboody, K S, Swanson, K R, Moats, R A, Lesniak, M S

    Published in Cancer gene therapy (01-01-2015)
    “…In preclinical studies, neural stem cell (NSC)-based delivery of oncolytic virus has shown great promise in the treatment of malignant glioma. Ensuring the…”
    Get full text
    Journal Article
  6. 6

    Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model by Thaci, B, Ahmed, A U, Ulasov, I V, Tobias, A L, Han, Y, Aboody, K S, Lesniak, M S

    Published in Cancer gene therapy (01-06-2012)
    “…Oncolytic virotherapy is a promising novel therapy for glioblastoma that needs to be optimized before introduced to clinic. The targeting of conditionally…”
    Get full text
    Journal Article
  7. 7

    Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy by Auffinger, B, Tobias, A L, Han, Y, Lee, G, Guo, D, Dey, M, Lesniak, M S, Ahmed, A U

    Published in Cell death and differentiation (01-07-2014)
    “…Glioblastoma multiforme patients have a poor prognosis due to therapeutic resistance and tumor relapse. It has been suggested that gliomas are driven by a rare…”
    Get full text
    Journal Article
  8. 8

    Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma by Thaci, B, Ahmed, A U, Ulasov, I V, Wainwright, D A, Nigam, P, Auffinger, B, Tobias, A L, Han, Y, Zhang, L, Moon, K-S, Lesniak, M S

    Published in Cancer gene therapy (01-01-2014)
    “…Myeloid-derived suppressor cells (MDSCs) accumulate in the glioma microenvironment during tumor progression and promote immunosuppression. Interleukin-12…”
    Get full text
    Journal Article
  9. 9

    Highly tunable perpendicularly magnetized synthetic antiferromagnets for biotechnology applications by Vemulkar, T, Mansell, R, Petit, D C M C, Cowburn, R P, Lesniak, M S

    Published in Applied physics letters (06-07-2015)
    “…Magnetic micro and nanoparticles are increasingly used in biotechnological applications due to the ability to control their behavior through an externally…”
    Get full text
    Journal Article
  10. 10

    Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats by Sonabend, A M, Ulasov, I V, Han, Y, Rolle, C E, Nandi, S, Cao, D, Tyler, M A, Lesniak, M S

    Published in Cancer gene therapy (01-04-2009)
    “…Conditionally replicative adenoviruses (CRAds) are often evaluated in mice; however, normal and cancerous mouse tissues are poorly permissive for human CRAds…”
    Get full text
    Journal Article
  11. 11

    MicroRNA targeting as a therapeutic strategy against glioma by Auffinger, B, Thaci, B, Ahmed, A, Ulasov, I, Lesniak, M S

    Published in Current molecular medicine (01-05-2013)
    “…Glioblastoma multiforme (GBM), the most common and aggressive form of primary brain tumor, presents a dismal prognosis. Current standard therapies are only…”
    Get more information
    Journal Article
  12. 12

    Low pressure hydrocephalus and ventriculomegaly: hysteresis, non-linear dynamics, and the benefits of CSF diversion by Lesniak, M. S., Clatterbuck, R. E., Rigamonti, D., Williams, M. A.

    Published in British journal of neurosurgery (2002)
    “…Low pressure hydrocephalus (LPH) is a rare clinical condition. We report our experience with 10 patients treated at the Johns Hopkins Hospital. We reviewed the…”
    Get full text
    Journal Article
  13. 13

    Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation by Thaci, B, Ulasov, I V, Ahmed, A U, Ferguson, S D, Han, Y, Lesniak, M S

    Published in Gene therapy (01-03-2013)
    “…Conditionally replicating adenoviruses (CRAd) are a promising class of gene therapy agents that can overcome already known glioblastoma (GBM) resistance…”
    Get full text
    Journal Article
  14. 14

    Characterization of infectivity of knob-modified adenoviral vectors in glioma by Paul, C.P.L., Everts, M., Dent, P., Fisher, P.B., Ulasov, I.V., Lesniak, M.S., Stoff-Khalili, M.A., Roth, J.C., Glasgow, J.N., Preuss, M.A., Dirven, C.M.F., Lamfers, M.L.M., Siegal, Gene P., Zhu, Z.B., Curiel, D.T.

    Published in Cancer biology & therapy (01-05-2008)
    “…Malignant gliomas have been a major target for gene therapy and virotherapy, because of their current lack of effective treatment. These approaches remain…”
    Get full text
    Journal Article
  15. 15

    Sui generis: gene therapy and delivery systems for the treatment of glioblastoma by Kane, J Robert, Miska, Jason, Young, Jacob S, Kanojia, Deepak, Kim, Julius W, Lesniak, Maciej S

    Published in Neuro-oncology (Charlottesville, Va.) (01-03-2015)
    “…Gene therapy offers a multidimensional set of approaches intended to treat and cure glioblastoma (GBM), in combination with the existing standard-of-care…”
    Get full text
    Journal Article
  16. 16

    Cytomegalovirus and glioma: putting the cart before the horse by Dey, Mahua, Ahmed, Atique U, Lesniak, Maciej S

    “…In 1908, Oluf Bang and Vilhelm Ellerman laid the foundation for theory of oncoviruses by demonstrating that the avian erythroblastosis (a form of chicken…”
    Get full text
    Journal Article Book Review
  17. 17

    P08.01 Tumor cell subpopulation changes during intracranial glioblastoma patient derived xenograft recurrence following radiation, temozolomide, or combination therapy by Ahmed, A. U., Horbinski, C. M., Stupp, R., Lesniak, M. S., James, C. D.

    Published in Neuro-oncology (Charlottesville, Va.) (01-05-2017)
    “…We’ve established a model for recurrent GBM by treating mice bearing previously untreated, luciferase-modified, intracranial GBM PDX, with radiation (RT) (2…”
    Get full text
    Journal Article
  18. 18
  19. 19

    P11.01 Intranasal delivery of mesenchymal stem cells targets diffuse intrinsic pontine glioma in mouse model by Chastkofsky, M. I., Procissi, D., Yang, C., Goldman, S., Lesniak, M. S., Hashizume, R., Balyasnikova, I. V.

    Published in Neuro-oncology (Charlottesville, Va.) (01-05-2017)
    “…Diffuse Intrinsic Pontine Glioma (DIPG) is a high-grade pediatric brainstem glioma afflicting children 7-9 years of age. The anatomic and diffuse…”
    Get full text
    Journal Article
  20. 20

    Comparative analysis of paracrine immunotherapy in experimental brain tumors by Lesniak, M S, Sampath, P, DiMeco, F, Viglione, M P, Tyler, B M, Pardoll, D M, Brem, H

    Published in Neurosurgical focus (15-12-2000)
    “…Local delivery of cytokines has been shown to have a potent antitumor activity against a wide range of malignant brain tumors. In this study, the authors…”
    Get full text
    Journal Article